Phillip Newman, NP
Nurse Practitioner · Belmont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 24
- Since medical school
- 9 years
- Graduated 2017
Offices
24 locations · CA Post Acute Specialists PC · Tahoe Forest Hospital District · Post Acute Specialists LLC · In Post Acute Specialists PC · Mi Post Acute Specialists PC · Bay Area Hospital District
Hospitals listed: Bay Area Hospital · Curry General Hospital · 215133. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Phillip Newman’s office to ask if they take your plan before you enroll.
State licence records
1 licence
- Washington ARNP.AP.61417380-NPAdvanced Registered Nurse Practitioner License · since 2023 · expires 2024-01-30ExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Bay Area HospitalCoos Bay, ORAcute Care Hospital · Government - Hospital District or Authority · Has an emergency departmentPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 2 of 5 starsNo measure marked better or worse than the national rate
- Curry General HospitalGold Beach, ORCritical Access Hospital · Government - Hospital District or Authority · Has an emergency department84% would definitely recommend itOverall rating: 2 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Bay Area Hospital
Behind the star rating — Deaths: 0 better, 6 the same, 1 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.78 (0.8 to 2.75) · 578 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.15 (0.8 to 1.49) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 168.57 (113.14 to 224.01) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.8 · 126 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13 · 216 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14.6 · 373 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.5 · 169 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 1,691 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.3 (0.08 to 0.51) · 4,318 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.35 (0.14 to 0.55) · 4,304 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.31 (1.17 to 5.45) · 869 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.21 (0.64 to 3.79) · 321 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.92 (0.34 to 3.49) · 841 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.17 (0.74 to 15.61) · 324 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.15 (0.62 to 7.69) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.23 (0.77 to 3.69) · 217 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.18 (0.41 to 1.94) · 3,188 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 6.7 · 96 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.914 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.28 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.753 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.945 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.545 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 214 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 441 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -7.4 · 204 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 28.4 · 413 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.8 · 340 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 345 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.9 to 7.9) · 220 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.7 (7.3 to 13) · 220 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 9.2 · 97 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.5 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12 (9 to 16) · 214 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.5) · 347 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,158 patients answered, 23% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Curry General Hospital
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 0 better, 3 the same, 1 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for COPD patientsComplications and deaths | 9.8 · 33 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.7 · 48 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 19 · 83 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 6.8 · 218 cases | None | Jul 2024 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.8 · 46 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 44.5 · 56 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -9.1 · 80 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.5 · 31 cases | None | Jul 2023 – Jun 2025 |
| Room was "always" clean | 92% |
| Nurses "always" communicated well | 86% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 73% |
| Yes, staff "did" give patients this information | 91% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 89% |
| Nurses "always" explained things so they could understand | 80% |
| Nurses "always" listened carefully | 86% |
| Nurses "always" treated them with courtesy and respect | 91% |
| "Always" quiet at night | 70% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 57% |
| Yes, staff "did" give patients information about possible symptoms | 95% |
Original Medicare doctor bills
$130,963
Medicare paid this office $130,963 for 2,114 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 1,144 | $60,689 | $50 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 236 | $17,224 | $71 |
| Return visit (30+ min) | 235 | $16,870 | $55 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 126 | $9,757 | $74 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 126 | $9,037 | $48 |
See all 12 services
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 1,144 | $60,689 | $50 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 236 | $17,224 | $71 |
| Return visit (30+ min) | 235 | $16,870 | $55 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 126 | $9,757 | $74 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 126 | $9,037 | $48 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 252 | $6,901 | $27 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 30 | $3,136 | $105 |
| Short return visit (20+ min) | 29 | $1,148 | $40 |
| Telephone medical discussion with physician, 11-20 minutes | 16 | $1,101 | $58 |
| New patient visit (45+ min) | 13 | $1,030 | $79 |
| Telephone medical discussion with physician, 5-10 minutes | 16 | $624 | $37 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 31 | $247 | $8 |
Who their Medicare patients are
2,114 Original Medicare patients in 2024. Average age 78 · Under 65 8% · 85 and older 29% · Women 56% · Also on Medicaid 41% · Health risk score 2.47. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Heart failure 56% · Coronary heart disease 55% · Depression 55% · Diabetes 51% · Chronic kidney disease 51% · Atrial fibrillation 45% · Dementia 45% · COPD 38% · Stroke 27% · Cancer 19%.
The office billed $521,326, Medicare allowed $171,043 and paid $130,963; for 2,559 services of 30 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 2,114 | 2,559 | 78 | 2.47 | $521,326 | $130,963 |
| 2023 | 559 | 703 | 74 | 2.77 | $159,485 | $31,502 |
| 2022 | 571 | 706 | 75 | 2.89 | $61,936 | $19,758 |
| 2021 | 178 | 294 | 75 | 1.56 | $24,986 | $12,750 |
| 2020 | 144 | 227 | 74 | 1.52 | $18,916 | $7,635 |
| 2019 | 347 | 555 | 75 | 1.91 | $67,421 | $22,148 |
| 2018 | 202 | 292 | 74 | 1.91 | $42,470 | $14,819 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Return visit (30+ min) | 176 | $12,663 | $64 |
| Telephone medical discussion with physician, 5-10 minutes | 163 | $4,467 | $22 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 77 | $4,069 | $51 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $2,890 | $51 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $2,204 | $85 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 25 | $1,289 | $50 |
| Telephone medical discussion with physician, 11-20 minutes | 15 | $703 | $44 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 37 | $490 | $13 |
| Short return visit (20+ min) | 11 | $480 | $44 |
| Short return visit | 13 | $285 | $20 |
2022: 5 services
| Telephone medical discussion with physician, 5-10 minutes | 444 | $12,551 | $24 |
| Telephone medical discussion with physician, 11-20 minutes | 46 | $1,989 | $43 |
| Return visit (30+ min) | 21 | $1,408 | $59 |
| Short return visit (20+ min) | 29 | $1,235 | $36 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 13 | $56 | $4 |
2021: 3 services
| Return visit (30+ min) | 108 | $7,999 | $64 |
| Short return visit (20+ min) | 72 | $3,039 | $41 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 55 | $358 | $6 |
2020: 3 services
| Return visit (30+ min) | 64 | $3,801 | $52 |
| Short return visit (20+ min) | 66 | $2,330 | $34 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 45 | $269 | $5 |
2019: 7 services
| Return visit (30+ min) | 128 | $7,237 | $49 |
| Short return visit (20+ min) | 161 | $5,627 | $31 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $3,613 | $134 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $1,348 | $48 |
| Long return visit (40+ min) | 14 | $1,028 | $73 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $548 | $26 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 65 | $412 | $6 |
2018: 6 services
| Return visit (30+ min) | 61 | $3,487 | $52 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,095 | $135 |
| Short return visit (20+ min) | 66 | $2,311 | $34 |
| Return visit (30+ min) | 25 | $1,682 | $67 |
| Long return visit (40+ min) | 12 | $883 | $74 |
| Short return visit (20+ min) | 16 | $731 | $46 |
Medicaid work
$17,293 in 2024
Medicaid paid $17,293 for 424 billed services this clinician did in 2024, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Hospital outpatient clinic visit for assessment and management of a patient | 139 | $7,889 |
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 195 | $4,296 |
| Return visit (30+ min) | 74 | $3,744 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 16 | $1,365 |
| 2024 | 424 | 4 | 22 | $17,293 |
| 2023 | 488 | 5 | 45 | $13,968 |
| 2022 | 417 | 2 | 41 | $1,416 |
| 2019 | 13 | 1 | 12 | $184 |
| 2018 | 14 | 1 | 14 | $174 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 112 | $5,325 |
| Hospital outpatient clinic visit for assessment and management of a patient | 93 | $4,956 |
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 197 | $3,237 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 69 | $386 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 17 | $65 |
2022
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 400 | $1,416 |
| Discharge medications reconciled with the current medication list in outpatient medical record (COA) (GER) | 17 | $0 |
2019
| Hospital outpatient clinic visit for assessment and management of a patient | 13 | $184 |
2018
| Hospital outpatient clinic visit for assessment and management of a patient | 14 | $174 |
Drugs they prescribed that Part D paid
$422,602
Pharmacies billed $422,602 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (38 of 2,240) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.
1,815 generic and 425 brand-name prescriptions · $422,602 in drug cost · 49 antibiotic prescriptions to 27 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 138 | $139,006 | $1,007 |
| Jardiance | 120 | $96,945 | $808 |
| Entresto | 46 | $56,702 | $1,233 |
| Repatha Sureclick | 22 | $19,546 | $888 |
| Ranolazine Er | 64 | $5,066 | $79 |
See all 40 drugs
| Eliquis | 138 | $139,006 | $1,007 |
| Jardiance | 120 | $96,945 | $808 |
| Entresto | 46 | $56,702 | $1,233 |
| Repatha Sureclick | 22 | $19,546 | $888 |
| Ranolazine Er | 64 | $5,066 | $79 |
| Metoprolol | 211 | $3,230 | $15 |
| Dabigatran Etexilate | 17 | $2,960 | $174 |
| Clopidogrel | 92 | $1,327 | $14 |
| Flecainide Acetate | 43 | $1,282 | $30 |
| Atorvastatin | 131 | $1,267 | $10 |
| Isosorbide Mononitrate Er | 99 | $1,003 | $10 |
| Digoxin | 37 | $989 | $27 |
| Riluzole | 11 | $956 | $87 |
| Rosuvastatin | 62 | $925 | $15 |
| Bumetanide | 16 | $866 | $54 |
| Diltiazem 24hr Er (Cd) | 50 | $621 | $12 |
| Lisinopril | 51 | $593 | $12 |
| Metoprolol | 58 | $560 | $10 |
| Potassium Chloride | 45 | $522 | $12 |
| Spironolactone | 83 | $507 | $6 |
| Amlodipine Besylate | 50 | $442 | $9 |
| Carvedilol | 42 | $409 | $10 |
| Losartan | 65 | $399 | $6 |
| Nitroglycerin | 24 | $395 | $16 |
| Nifedipine Er | 30 | $394 | $13 |
| Tamsulosin | 20 | $388 | $19 |
| Furosemide | 72 | $364 | $5 |
| Amiodarone | 14 | $359 | $26 |
| Cartia Xt | 12 | $327 | $27 |
| Clonidine | 11 | $212 | $19 |
| Finasteride | 11 | $209 | $19 |
| Sulfamethoxazole-Trimethoprim | 13 | $200 | $15 |
| Cilostazol | 11 | $170 | $15 |
| Enulose | 13 | $167 | $13 |
| Pantoprazole | 24 | $166 | $7 |
| Hydralazine | 11 | $160 | $15 |
| Oxycodone | 22 | $116 | $5 |
| Hydrochlorothiazide | 18 | $106 | $6 |
| Bisoprolol | 11 | $94 | $9 |
| Warfarin | 13 | $58 | $4 |
Year by year
| 2024 | 2,240 | 499 | 2% (38) | 19% | $422,602 |
| 2023 | 967 | 539 | 2% (15) | None | $88,618 |
| 2022 | 3,428 | 869 | None | None | $611,788 |
| 2021 | 5,428 | 1,027 | 0% (0) | 20% | $891,082 |
| 2020 | 5,161 | 907 | 0% (0) | 20% | $681,615 |
| 2019 | 8,754 | 1,049 | 0% (0) | 18% | $947,105 |
| 2018 | 1,308 | 392 | 0% (0) | 20% | $115,719 |
| 2017 | 14 | None | 0% (0) | None | $456 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Eliquis | 34 | $25,681 | $755 |
| Metoprolol | 43 | $911 | $21 |
| Clopidogrel | 87 | $695 | $8 |
| Nitrofurantoin | 20 | $583 | $29 |
| Nitroglycerin | 26 | $568 | $22 |
| Ondansetron | 33 | $535 | $16 |
| Rosuvastatin | 18 | $452 | $25 |
| Atorvastatin | 34 | $368 | $11 |
| Nifedipine Er | 22 | $362 | $16 |
| Losartan | 30 | $290 | $10 |
| Potassium Chloride | 22 | $290 | $13 |
| Midodrine | 12 | $277 | $23 |
| Sulfamethoxazole-Trimethoprim | 30 | $263 | $9 |
| Furosemide | 51 | $213 | $4 |
| Isosorbide Mononitrate Er | 20 | $209 | $10 |
| Hydralazine | 14 | $184 | $13 |
| Ciprofloxacin | 12 | $147 | $12 |
| Cephalexin | 11 | $116 | $11 |
| Spironolactone | 18 | $101 | $6 |
| Metoprolol | 13 | $82 | $6 |
| Ibuprofen | 13 | $75 | $6 |
| Amlodipine Besylate | 17 | $41 | $2 |
2022: 38 drugs
| Eliquis | 420 | $379,448 | $903 |
| Xarelto | 59 | $54,159 | $918 |
| Repatha Sureclick | 53 | $41,833 | $789 |
| Entresto | 32 | $31,110 | $972 |
| Brilinta | 30 | $18,709 | $624 |
| Metoprolol | 327 | $6,501 | $20 |
| Diltiazem 24hr Er (Cd) | 98 | $5,007 | $51 |
| Atorvastatin | 328 | $4,575 | $14 |
| Clopidogrel | 278 | $3,814 | $14 |
| Ranolazine Er | 31 | $2,488 | $80 |
| Amiodarone | 87 | $1,746 | $20 |
| Losartan | 141 | $1,698 | $12 |
| Potassium Chloride | 57 | $1,176 | $21 |
| Carvedilol | 123 | $1,171 | $10 |
| Isosorbide Mononitrate Er | 104 | $1,144 | $11 |
| Rosuvastatin | 18 | $1,086 | $60 |
| Lisinopril | 111 | $900 | $8 |
| Furosemide | 228 | $895 | $4 |
| Ezetimibe | 23 | $817 | $36 |
| Amlodipine Besylate | 106 | $721 | $7 |
| Diltiazem 24hr Er | 24 | $683 | $28 |
| Digoxin | 14 | $640 | $46 |
| Warfarin | 38 | $618 | $16 |
| Metoprolol | 111 | $593 | $5 |
| Nitrofurantoin | 13 | $524 | $40 |
| Hydrochlorothiazide | 76 | $486 | $6 |
| Nifedipine Er | 13 | $477 | $37 |
| Fenofibrate | 12 | $476 | $40 |
| Spironolactone | 41 | $387 | $9 |
| Nitroglycerin | 14 | $361 | $26 |
| Dilt-Xr | 11 | $287 | $26 |
| Ondansetron | 18 | $261 | $15 |
| Nebivolol | 11 | $255 | $23 |
| Pravastatin | 14 | $243 | $17 |
| Sulfamethoxazole-Trimethoprim | 24 | $200 | $8 |
| Simvastatin | 25 | $182 | $7 |
| Lisinopril-Hydrochlorothiazide | 11 | $77 | $7 |
| Atenolol | 14 | $54 | $4 |
2021: 45 drugs
| Eliquis | 532 | $469,033 | $882 |
| Xarelto | 133 | $134,685 | $1,013 |
| Entresto | 90 | $86,165 | $957 |
| Repatha Sureclick | 55 | $33,932 | $617 |
| Brilinta | 50 | $31,072 | $621 |
| Praluent | 18 | $15,477 | $860 |
| Pradaxa | 14 | $14,339 | $1,024 |
| Metoprolol | 572 | $13,743 | $24 |
| Ranolazine Er | 61 | $12,686 | $208 |
| Atorvastatin | 537 | $8,362 | $16 |
| Diltiazem 24hr Er (Cd) | 153 | $7,552 | $49 |
| Clopidogrel | 449 | $5,188 | $12 |
| Losartan | 211 | $2,770 | $13 |
| Fenofibrate | 39 | $2,572 | $66 |
| Rosuvastatin | 65 | $2,445 | $38 |
| Amiodarone | 121 | $2,130 | $18 |
| Ezetimibe | 26 | $2,122 | $82 |
| Metoprolol | 261 | $2,035 | $8 |
| Carvedilol | 225 | $1,903 | $8 |
| Furosemide | 363 | $1,621 | $4 |
| Pacerone | 22 | $1,453 | $66 |
| Lisinopril | 212 | $1,452 | $7 |
| Acebutolol | 13 | $1,348 | $104 |
| Isosorbide Mononitrate Er | 139 | $1,346 | $10 |
| Potassium Chloride | 59 | $1,271 | $22 |
| Warfarin | 92 | $1,241 | $13 |
| Pravastatin | 57 | $1,122 | $20 |
| Digoxin | 38 | $907 | $24 |
| Nitroglycerin | 21 | $896 | $43 |
| Amlodipine Besylate | 147 | $837 | $6 |
| Spironolactone | 79 | $820 | $10 |
| Hydrochlorothiazide | 105 | $796 | $8 |
| Diltiazem 24hr Er | 17 | $685 | $40 |
| Cilostazol | 31 | $632 | $20 |
| Metolazone | 21 | $630 | $30 |
| Sotalol | 21 | $621 | $30 |
| Nifedipine Er | 17 | $618 | $36 |
| Valsartan | 17 | $587 | $35 |
| Simvastatin | 45 | $553 | $12 |
| Cartia Xt | 17 | $528 | $31 |
| Losartan-Hydrochlorothiazide | 18 | $519 | $29 |
| Pantoprazole | 17 | $208 | $12 |
| Lisinopril-Hydrochlorothiazide | 32 | $138 | $4 |
| Atenolol | 14 | $121 | $9 |
| Hydralazine | 11 | $16 | $1 |
2020: 46 drugs
| Eliquis | 442 | $339,321 | $768 |
| Xarelto | 102 | $75,851 | $744 |
| Brilinta | 75 | $43,690 | $583 |
| Entresto | 54 | $37,764 | $699 |
| Repatha Sureclick | 52 | $33,595 | $646 |
| Ranolazine Er | 59 | $21,799 | $369 |
| Pradaxa | 35 | $18,773 | $536 |
| Livalo | 18 | $11,059 | $614 |
| Vascepa | 18 | $10,911 | $606 |
| Metoprolol | 502 | $10,647 | $21 |
| Diltiazem 24hr Er (Cd) | 83 | $8,566 | $103 |
| Atorvastatin | 534 | $7,525 | $14 |
| Clopidogrel | 456 | $5,244 | $12 |
| Amiodarone | 129 | $2,441 | $19 |
| Carvedilol | 250 | $2,133 | $9 |
| Warfarin | 99 | $2,116 | $21 |
| Fenofibrate | 33 | $2,093 | $63 |
| Cartia Xt | 69 | $2,090 | $30 |
| Rosuvastatin | 51 | $2,061 | $40 |
| Losartan | 185 | $1,950 | $11 |
| Potassium Chloride | 87 | $1,912 | $22 |
| Isosorbide Mononitrate Er | 133 | $1,875 | $14 |
| Metoprolol | 209 | $1,403 | $7 |
| Furosemide | 298 | $1,320 | $4 |
| Pravastatin | 62 | $1,201 | $19 |
| Lisinopril | 216 | $1,200 | $6 |
| Acebutolol | 16 | $1,133 | $71 |
| Nitroglycerin | 34 | $1,131 | $33 |
| Diltiazem 24hr Er | 22 | $916 | $42 |
| Labetalol | 20 | $901 | $45 |
| Hydrochlorothiazide | 108 | $849 | $8 |
| Propranolol Hcl Er | 11 | $804 | $73 |
| Nifedipine Er | 31 | $796 | $26 |
| Metolazone | 15 | $755 | $50 |
| Spironolactone | 88 | $751 | $9 |
| Bumetanide | 13 | $684 | $53 |
| Amlodipine Besylate | 130 | $667 | $5 |
| Digoxin | 23 | $568 | $25 |
| Sotalol | 16 | $525 | $33 |
| Simvastatin | 43 | $441 | $10 |
| Atenolol | 35 | $396 | $11 |
| Losartan-Hydrochlorothiazide | 12 | $341 | $28 |
| Lisinopril-Hydrochlorothiazide | 41 | $236 | $6 |
| Cilostazol | 13 | $233 | $18 |
| Lovastatin | 12 | $153 | $13 |
| Omeprazole | 16 | $149 | $9 |
2019: 63 drugs
| Eliquis | 621 | $442,789 | $713 |
| Xarelto | 139 | $119,914 | $863 |
| Brilinta | 142 | $75,409 | $531 |
| Entresto | 60 | $33,692 | $562 |
| Pradaxa | 34 | $27,965 | $823 |
| Ranexa | 34 | $22,052 | $649 |
| Ranolazine Er | 71 | $19,582 | $276 |
| Metoprolol | 791 | $18,051 | $23 |
| Atorvastatin | 921 | $15,385 | $17 |
| Livalo | 37 | $15,103 | $408 |
| Diltiazem 24hr Er (Cd) | 129 | $10,427 | $81 |
| Repatha Sureclick | 20 | $9,726 | $486 |
| Clopidogrel | 848 | $9,613 | $11 |
| Amiodarone | 243 | $6,244 | $26 |
| Rosuvastatin | 137 | $5,450 | $40 |
| Cartia Xt | 191 | $5,421 | $28 |
| Warfarin | 176 | $4,116 | $23 |
| Carvedilol | 487 | $4,003 | $8 |
| Prasugrel | 24 | $3,653 | $152 |
| Dexilant | 12 | $3,462 | $289 |
| Isosorbide Mononitrate Er | 219 | $3,158 | $14 |
| Potassium Chloride | 108 | $2,962 | $27 |
| Metoprolol | 410 | $2,934 | $7 |
| Ezetimibe | 28 | $2,903 | $104 |
| Lisinopril | 431 | $2,856 | $7 |
| Losartan | 247 | $2,687 | $11 |
| Pravastatin | 111 | $2,681 | $24 |
| Furosemide | 423 | $2,530 | $6 |
| Toprol Xl | 49 | $2,463 | $50 |
| Nifedipine Er | 59 | $2,283 | $39 |
| Labetalol | 36 | $2,182 | $61 |
| Diltiazem 24hr Er (La) | 20 | $1,858 | $93 |
| Amlodipine Besylate | 237 | $1,839 | $8 |
| Nitroglycerin | 68 | $1,553 | $23 |
| Bumetanide | 23 | $1,511 | $66 |
| Diltiazem 24hr Er | 41 | $1,493 | $36 |
| Olmesartan Medoxomil | 45 | $1,446 | $32 |
| Flecainide Acetate | 21 | $1,368 | $65 |
| Spironolactone | 157 | $1,297 | $8 |
| Digoxin | 35 | $1,139 | $33 |
| Propranolol Hcl Er | 11 | $1,108 | $101 |
| Acebutolol | 27 | $1,022 | $38 |
| Pacerone | 13 | $1,021 | $79 |
| Fenofibrate | 11 | $856 | $78 |
| Hydrochlorothiazide | 107 | $834 | $8 |
| Cilostazol | 48 | $821 | $17 |
| Sotalol | 18 | $728 | $40 |
| Simvastatin | 78 | $673 | $9 |
| Propafenone | 16 | $671 | $42 |
| Fenofibrate | 18 | $619 | $34 |
| Atenolol | 58 | $499 | $9 |
| Lisinopril-Hydrochlorothiazide | 80 | $495 | $6 |
| Dilt-Xr | 13 | $491 | $38 |
| Irbesartan | 13 | $379 | $29 |
| Hydralazine | 17 | $353 | $21 |
| Losartan-Hydrochlorothiazide | 40 | $322 | $8 |
| Klor-Con M20 | 11 | $311 | $28 |
| Lovastatin | 12 | $252 | $21 |
| Ramipril | 14 | $230 | $16 |
| Verapamil Er | 12 | $177 | $15 |
| Pantoprazole | 14 | $175 | $13 |
| Omeprazole | 21 | $141 | $7 |
| Clonidine | 15 | $85 | $6 |
2018: 24 drugs
| Eliquis | 86 | $52,442 | $610 |
| Brilinta | 32 | $16,352 | $511 |
| Ranexa | 13 | $6,622 | $509 |
| Prasugrel | 14 | $2,550 | $182 |
| Atorvastatin | 161 | $2,028 | $13 |
| Metoprolol | 116 | $1,986 | $17 |
| Nitroglycerin | 24 | $1,972 | $82 |
| Clopidogrel | 183 | $1,801 | $10 |
| Diltiazem 24hr Er (Cd) | 24 | $1,114 | $46 |
| Isosorbide Mononitrate Er | 37 | $777 | $21 |
| Rosuvastatin | 20 | $676 | $34 |
| Warfarin | 26 | $477 | $18 |
| Cartia Xt | 30 | $472 | $16 |
| Nifedipine Er | 13 | $401 | $31 |
| Amiodarone | 27 | $382 | $14 |
| Losartan | 46 | $371 | $8 |
| Carvedilol | 46 | $326 | $7 |
| Metoprolol | 49 | $317 | $6 |
| Amlodipine Besylate | 37 | $282 | $8 |
| Pravastatin | 18 | $274 | $15 |
| Lisinopril | 54 | $258 | $5 |
| Furosemide | 70 | $252 | $4 |
| Spironolactone | 24 | $165 | $7 |
| Losartan-Hydrochlorothiazide | 14 | $89 | $6 |
Money from drug and device companies
$244 in 2025
| 2025 | 5 | 7 | None | $244 |
| 2024 | 1 | 2 | None | $138 |
| 2023 | 1 | 7 | None | $684 |
| 2022 | 1 | 1 | None | $73 |
| 2021 | 1 | 2 | None | $47 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abiomed | None | $150 | 2 payments
|
| Penumbra | Indigo System | $33 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $30 | 2 payments
|
| Medtronic | Linq II | $16 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $14 | 1 payment
|
See all 7 published payments
| Bayer Healthcare Pharmaceuticals | Meals · 2025-10-17 | Kerendia | $14 |
| Novartis Pharmaceuticals | Meals · 2025-09-23 | Leqvio | $14 |
| Medtronic | Meals · 2025-09-23 | Linq II | $16 |
| Abiomed | Meals · 2025-08-05 | None | $107 |
| Abiomed | Meals · 2025-07-23 | None | $43 |
| Novartis Pharmaceuticals | Meals · 2025-07-01 | Leqvio | $16 |
| Penumbra | Meals · 2025-03-19 | Indigo System | $33 |
See earlier years (2024, 2023, 2022, 2021)
2024: $138
| Penumbra | Indigo System | $138 | 2 payments
|
2023: $684
| Medtronic | None | $684 | 7 payments
|
2022: $73
| Kiniksa Pharmaceuticals | Arcalyst | $73 | 1 payment
|
2021: $47
| Abbott Laboratories | Perclose Proglide Suture Mediated Closure System | $47 | 2 payments
|
Professional record
- NPI
- 1427579895
- Licence
- OH APRN.CNP.021530, OH RN424716, WA AP61417380Washington ARNP.AP.61417380-NP: Expired
- Group
- CA Post Acute Specialists PC · Tahoe Forest Hospital District · Post Acute Specialists LLC · In Post Acute Specialists PC · Mi Post Acute Specialists PC · Bay Area Hospital District
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X); Federal specialty code 163W00000X (163W00000X); Federal specialty code 363LG0600X (363LG0600X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2017-07-06
- NPI last updated
- 2025-12-17
- NPI record certified
- 2025-12-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1330 Coshocton Ave, Mount Vernon, OH, 43050 · 888 Swift Blvd, Richland, WA, 99352 · 10121 Pine Ave, Truckee, CA, 96161